O'Malley DM - Search Results

1

Wound complications following vulvar excision for nonmalignant lesions.

Boyles GP, Weaver AM, Cohn DE, Backes FJ, Copeland LJ, Bixel KL, Fowler JM, O'Malley DM, Cosgrove CM. Boyles GP, et al. AJOG Glob Rep. 2021 Oct 6;1(4):100022. doi: 10.1016/j.xagr.2021.100022. eCollection 2021 Nov. AJOG Glob Rep. 2021. PMID: 36277453 Free PMC article.

2

Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus.

Saini U, Smith BQ, Dorayappan KDP, Yoo JY, Maxwell GL, Kaur B, Konishi I, O'Malley D, Cohn DE, Selvendiran K. Saini U, et al. J Ovarian Res. 2022 Dec 7;15(1):130. doi: 10.1186/s13048-022-01054-5. J Ovarian Res. 2022. PMID: 36476493 Free PMC article.

3

Correction: Targeting TMEM205 mediated drug resistance in ovarian clear cell carcinoma using oncolytic virus.

Saini U, Smith BQ, Dorayappan KDP, Yoo JY, Maxwell GL, Kaur B, Konishi I, O'Malley D, Cohn DE, Selvendiran K. Saini U, et al. J Ovarian Res. 2023 Feb 13;16(1):38. doi: 10.1186/s13048-023-01111-7. J Ovarian Res. 2023. PMID: 36782250 Free PMC article. No abstract available.

4

The right time for change: A report on the heterogeneity of IVB endometrial cancer and improved risk-stratification provided by new 2023 FIGO staging criteria.

Haight PJ, Riedinger CJ, Backes FJ, O'Malley DM, Cosgrove CM. Haight PJ, et al. Gynecol Oncol. 2023 Aug;175:32-40. doi: 10.1016/j.ygyno.2023.05.069. Epub 2023 Jun 13. Gynecol Oncol. 2023. PMID: 37321153

5

"More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok.

Morton M, Haight PJ, Khadraoui W, Backes F, Bixel K, O'Malley DM, Nagel C, Chambers LM. Morton M, et al. Gynecol Oncol. 2023 Aug;175:81-87. doi: 10.1016/j.ygyno.2023.06.004. Epub 2023 Jun 15. Gynecol Oncol. 2023. PMID: 37329872

6

Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer.

Morton M, Patterson J, Sciuva J, Perni J, Backes F, Nagel C, O'Malley DM, Chambers LM. Morton M, et al. Gynecol Oncol. 2023 Aug;175:142-155. doi: 10.1016/j.ygyno.2023.06.015. Epub 2023 Jun 27. Gynecol Oncol. 2023. PMID: 37385068 Review.

7

Evaluation of Efficacy and Adverse Events After Second Immunotherapy Exposure in Endometrial and Cervical Carcinoma.

Morton M, Marcu I, Levine M, Cosgrove C, Backes F, O'Malley D, Chambers L. Morton M, et al. Obstet Gynecol. 2023 Aug 1;142(2):360-363. doi: 10.1097/AOG.0000000000005243. Epub 2023 Jul 5. Obstet Gynecol. 2023. PMID: 37411031

8

Assessment of socioeconomic and racial differences in patients undergoing concurrent gynecologic oncology and urogynecology surgeries: a National Inpatient Sample (NIS) database study.

Marcu I, McLaughlin EM, Nekkanti S, Khadraoui W, Chalif J, Fulton J, O'Malley D, Chambers LM. Marcu I, et al. Int J Gynecol Cancer. 2024 May 6;34(5):751-759. doi: 10.1136/ijgc-2023-005130. Int J Gynecol Cancer. 2024. PMID: 38719274

9

Strategies for prevention and management of ocular events occurring with mirvetuximab soravtansine.

Hendershot A, Slabaugh M, Riaz KM, Moore KN, O'Malley DM, Matulonis U, Konecny GE. Hendershot A, et al. Gynecol Oncol Rep. 2023 Feb 28;47:101155. doi: 10.1016/j.gore.2023.101155. eCollection 2023 Jun. Gynecol Oncol Rep. 2023. PMID: 37102083 Free PMC article. Review.

10

The microbiome and gynecologic cancer: cellular mechanisms and clinical applications.

Chalif J, Wang H, Spakowicz D, Quick A, Arthur EK, O'Malley D, Chambers LM. Chalif J, et al. Int J Gynecol Cancer. 2024 Feb 5;34(2):317-327. doi: 10.1136/ijgc-2023-004894. Int J Gynecol Cancer. 2024. PMID: 38088183 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters